OsteoBoston presentations

OsteoBoston has some very useful presentations on osteoporosis. Here are two notifications for your consideration

OsteoBoston Member-what an amazing talk on Tuesday! Maybe you missed it or would like a review. It's a very exciting talk. Here is your video. Link is below and is prior to the description, the chapters and Dr. Wein's biosketch.
Thank you for a lively discussion afterwards!

Our next program is on Tuesday, April 7th when we welcome Lisa Moore, of Brick House Bones. More to follow on that, plus you'll be receiving the podcast of Dr. Wein.
Shelly G

Here is the video link to this talk with Dr. Marc Wein, MD, PHD, https://youtu.be/DtX_lDGohXs

In this program, Dr. Wein, , MD, PHD of Massachusetts General Hospital and Associate Professor at Harvard Medical School will be discussing new treatments under investigation, such as SK-124, as well as existing medications used to treat osteoporosis. These technologies were made possible due to the FDA’s approval of Bone Mass Density being the endpoint goal for new medications based on the SABRE recommendations. Previously, approval was based on incidence of fracture, which prolonged drug releases and delayed/prevented greater research into new medications. This is an exciting change for osteoporosis research. Here is the link to the Wein Laboratory https://www.youtube.com/watch (where some of the latest technology is currently taking place.) 3/2026 Here is a link to an article printed about the new oral medication currently under testing, SK-124 https://www.eurekalert.org/news-releases/973616. 00:00 Introduction 00:28 Speaker introduction 03:28 Presentations begins 03:52 Consequences of fracture 05:21 Ways to build bones 06:31 Current osteoporosis therapeutic landscape 07:05 Anti-resorptives 08:22 Building new bone with Anabolics 11:07 Innovation in osteoporosis drug development 14:43 Drug creation process 16:48 New development in osteoporosis drug development 19:37 Re-invigorated drug pipeline post-SABRE 23:50 Q&A break 26:11 3rd cell types in bone – osteocytes 28:21 Osteocytes: conductor of the bone remodeling orchestra 29:36 Parathyroid hormone 30:55 Parathyroid hormone actions in bone 33:33 SIK2/SIK3 proteins 39:13 Future osteoporosis therapeutic landscape 41:49 Q&A Dr. Marc Wein is an Associate Professor of Medicine at Harvard Medical School and an Associate Member of the Broad Institute. Marc received his B.S. and M.S. from Yale University, M.D. and Ph.D. from Harvard Medical School, and was trained in Internal Medicine and Endocrinology at Massachusetts General Hospital where he currently runs his research laboratory and clinical practice.

--
Shelly Gladstein, OsteoBoston
Bone Health and Osteoporosis Foundation
Support Group Facilitator

YouTube channel:
https://www.youtube.com/channel/UC2GQ9c1bFkQmkcQD3nIpJhQ
My story:
https://www.healthywomen.org/created-with-support/taking-on-mountains-and-osteoporosis
OsteoBoston's Guide to Online Resources for the patient with Osteoporosis:
https://drive.google.com/file/d/1_38xfeFFlzOI2Ln6vK4a9W9AgGxoQRQB/view
Website:
https://osteoboston.org/ (https://osteoboston.org/)

Email:
osteoboston@gmail.com

Please note that the information and opinions expressed on any of the programs during Zoom casts with our speakers ( or in written form) are intended to address specific questions asked or situations described on the program and are not designed to constitute complete and professional advice or recommendations.

Members of our group should not act on or rely upon any and all information contained in any of the zooms or written material shared without seeking the advice of other medical professionals in the field.